HK 1
Alternative Names: HK-1Latest Information Update: 02 Jan 2023
Price :
$50 *
At a glance
- Originator CUROME BIOSCIENCES
- Class
- Mechanism of Action NQO1 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Mitochondrial disorders
Most Recent Events
- 06 Dec 2022 Preclinical trials in Mitochondrial disorders in South Korea (unspecified route) (CUROME BIOSCIENCES pipeline, December 2022)